Pressure BioSciences, Inc. Stock

Equities

PBIO

US74112E2081

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 03:59:30 2024-04-19 pm EDT 5-day change 1st Jan Change
0.256 USD -5.08% Intraday chart for Pressure BioSciences, Inc. -13.66% -22.42%
Sales 2021 2M Sales 2022 1.73M Capitalization 15.89M
Net income 2021 -20M Net income 2022 -16M EV / Sales 2021 16.4 x
Net Debt 2021 14.51M Net Debt 2022 20.53M EV / Sales 2022 21.1 x
P/E ratio 2021
-0.68 x
P/E ratio 2022
-0.81 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 98.82%
More Fundamentals * Assessed data
Dynamic Chart
Pressure BioSciences, Inc. Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract Manufacturing CI
Transcript : CBH International LLC, Pressure BioSciences, Inc. - M&A Call
Pressure BioSciences, Inc. completed the acquisition of CBH International LLC. CI
Pressure BioSciences, Inc. Receives Open Order Agreement from West Coast Manufacturing Partner CI
Pressure BioSciences, Inc. entered into a definitive agreement to acquire CBH International LLC. CI
Pressure BioSciences' BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) Technologies CI
Pressure BioSciences, Inc. Announces the Publication of Pivotal Scientific Study in the Critical Field of Food Safety CI
Pressure BioSciences and Veterans Service Team Launch UltraShear Best-in-Class Nano-CBD Topical Spray - MMA Champ Cat Zingano Now Official VST Ambassador CI
Transcript : Pressure BioSciences, Inc., Q3 2023 Earnings Call, Nov 21, 2023
Earnings Flash (PBIO) PRESSURE BIOSCIENCES Reports Q3 Revenue $413,009 MT
Pressure BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Pressure Biosciences Announces Exclusive Distribution Agreement with Bioscreen Instruments Pvt Ltd CI
Pressure BioSciences' Partner Veterans Service Team Increases Existing Purchase Order by 10X for Bottles of UltraShear Nano-CBD Topical Spray, Effective Immediately CI
Transcript : Pressure BioSciences, Inc., Q2 2023 Earnings Call, Aug 22, 2023
Earnings Flash (PBIO) PRESSURE BIOSCIENCES Posts Q2 Revenue $511,800 MT
More news

Latest transcript on Pressure BioSciences, Inc.

1 day-5.08%
1 week-13.66%
Current month+46.12%
1 month+78.27%
3 months-39.03%
6 months-39.05%
Current year-22.42%
More quotes
1 week
0.22
Extreme 0.219
0.29
1 month
0.14
Extreme 0.14
0.31
Current year
0.14
Extreme 0.14
0.50
1 year
0.14
Extreme 0.14
1.07
3 years
0.14
Extreme 0.14
4.98
5 years
0.14
Extreme 0.14
4.98
10 years
0.14
Extreme 0.14
17.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 73 78-07-31
Chief Tech/Sci/R&D Officer 70 06-04-23
Chief Tech/Sci/R&D Officer 59 06-04-02
Members of the board TitleAgeSince
Chief Executive Officer 73 78-07-31
Director/Board Member 75 12-07-02
Director/Board Member 71 13-02-07
More insiders
Date Price Change Volume
24-04-19 0.256 -5.08% 28 800
24-04-18 0.2697 0.00% 37,260
24-04-17 0.2697 +7.88% 20,107
24-04-16 0.25 +0.12% 43,225
24-04-15 0.2497 -15.78% 47,845

Delayed Quote OTC Markets, April 19, 2024 at 03:59 pm EDT

More quotes
Pressure BioSciences, Inc. is engaged in providing broadly enabling, high pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical, and agrochemical, as well as food and beverage manufacturing. The Company's enabling platform, Pressure Cycling Technology (PCT), utilizes alternating cycles of pressure to control bio-molecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. The Company's BaroFold technology platform allows it to enter the bio-pharma contract services and GMP manufacturing equipment sector. It has also developed the scalable and pressure-based UltraShear Technology platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be preserved using existing non-thermal technologies.
More about the company